- Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
- Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
- Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
- Insulet to Present at Upcoming Investor Conferences
- Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency¹)
- Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
- Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
Insulet Corp (PODD:NSQ) closed at 234.19, 29.39% above the 52 week low of 181.00 set on May 12, 2022.
181.00May 12 2022324.81Nov 10 2021
Markit short selling activity
|Market cap||16.25bn USD|
|EPS (TTM)||0.4765 |
Data delayed at least 15 minutes, as of Sep 23 2022 21:00 BST.